The rapid rise of GLP-1 weight-loss drugs has come with a raucous side show—a wave of copycat drugs unbound by drug patents.

Dr. Marty Makary will answer questions from a Senate panel about his plans to lead the Food and Drug Administration ...

Danish drugmaker Novo Nordisk said Wednesday that it will drop prices 23% for all doses of Wegovy. The new monthly price of ...

Metformin is the most commonly prescribed oral drug for diabetes. Of course, if you or a loved one receives treatment for ...

As a federal court in Texas hears a case pitting the FDA versus compounders who want to continue to manufacture cheaper ...

Physicians need to meet patients ‘where they are’ to develop a comprehensive plan to keep weight off and live a healthy ...

Minnesota lawmakers are renewing a push to require insurance coverage of anti-obesity drugs like Ozempic and Wegovy. Why it ...

Administration of semaglutide before metabolic and bariatric surgery does not confer benefits for overall weight loss, ...

The rapid rise of GLP-1 weight-loss drugs has come with a raucous side show—a wave of copycat drugs unbound by drug patents.

Right now, doctors use semaglutides to treat diabetes and help with weight loss, but according to this small study, it’s possible it can help curb alcohol cravings. The study found that those who used ...

An expert Cleveland Clinic doctor reveals how much weight you can safely lose in a month and strategies to help you achieve ...

I followed the Mediterranean Diet for 30 days. Discover the surprising results, health benefits, and my experience with this ...